Latest P21 Stories
Unique delivery vehicle to be developed across p53 mutated solid tumors by delivering wild type p21 NEW YORK and ZUG, Switzerland, April 15, 2015 /PRNewswire/ -- SELLAS Life Sciences
It is perhaps impossible to overstate the importance of the tumor suppressor gene p53.
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells.
Scientists at the Salk Institute for Biological Studies have found clues to the functioning of an important damage response protein in cells.
When cells find themselves in a tight spot, the cell cycle regulator p21 halts the cell cycle, buying cells time to repair the damage, or if all else fails, to initiate programmed cell death.
BEVERLY, Mass., March 31, 2011 /PRNewswire/ -- Cellceutix Corporation (OTCQB: CTIX), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat severe medical conditions including drug-resistant cancers, is pleased to announce that additional research has been concluded on Kevetrin(TM), the Company's flagship cancer compound.
In the years since the AIDS epidemic began, it has become clear that there is substantial variation in the way that individuals respond to HIV infection.
- A hairdresser.